PL1802277T3 - Kompozycja liposomowa zawierająca aktywny składnik do rozluźniania mięśni gładkich, otrzymywania tej kompozycji i jej zastosowanie terapeutyczne - Google Patents
Kompozycja liposomowa zawierająca aktywny składnik do rozluźniania mięśni gładkich, otrzymywania tej kompozycji i jej zastosowanie terapeutyczneInfo
- Publication number
- PL1802277T3 PL1802277T3 PL05802312T PL05802312T PL1802277T3 PL 1802277 T3 PL1802277 T3 PL 1802277T3 PL 05802312 T PL05802312 T PL 05802312T PL 05802312 T PL05802312 T PL 05802312T PL 1802277 T3 PL1802277 T3 PL 1802277T3
- Authority
- PL
- Poland
- Prior art keywords
- active ingredient
- composition
- liposomes
- therapeutic use
- smooth muscles
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000002040 relaxant effect Effects 0.000 title abstract 2
- 210000002460 smooth muscle Anatomy 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract 5
- 239000002502 liposome Substances 0.000 abstract 3
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 abstract 2
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 abstract 1
- XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 abstract 1
- 108010078321 Guanylate Cyclase Proteins 0.000 abstract 1
- 102000014469 Guanylate cyclase Human genes 0.000 abstract 1
- -1 NO-synthetases Chemical compound 0.000 abstract 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 abstract 1
- 102000030621 adenylate cyclase Human genes 0.000 abstract 1
- 108060000200 adenylate cyclase Proteins 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 210000004392 genitalia Anatomy 0.000 abstract 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000002823 nitrates Chemical class 0.000 abstract 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003180 prostaglandins Chemical class 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 208000012201 sexual and gender identity disease Diseases 0.000 abstract 1
- 208000015891 sexual disease Diseases 0.000 abstract 1
- 230000001568 sexual effect Effects 0.000 abstract 1
- 229960003310 sildenafil Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Pregnancy & Childbirth (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04024753 | 2004-10-18 | ||
| EP05802312A EP1802277B1 (de) | 2004-10-18 | 2005-10-14 | Liposomale zusammensetzung einen wirkstoff zur relaxierung glatter muskulatur enthaltend, die herstellung dieser zusammensetzung und deren therapeutische verwendung |
| PCT/EP2005/011054 WO2006042701A1 (de) | 2004-10-18 | 2005-10-14 | Liposomale zusammensetzung einen wirkstoff zur relaxierung glatter muskulatur enthaltend, die herstellung dieser zusammensetzung und deren therapeutische verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1802277T3 true PL1802277T3 (pl) | 2010-07-30 |
Family
ID=35703778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05802312T PL1802277T3 (pl) | 2004-10-18 | 2005-10-14 | Kompozycja liposomowa zawierająca aktywny składnik do rozluźniania mięśni gładkich, otrzymywania tej kompozycji i jej zastosowanie terapeutyczne |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8524274B2 (pl) |
| EP (1) | EP1802277B1 (pl) |
| JP (1) | JP5688199B2 (pl) |
| KR (1) | KR101289917B1 (pl) |
| CN (1) | CN101043874A (pl) |
| AT (1) | ATE454884T1 (pl) |
| AU (1) | AU2005296719B2 (pl) |
| CA (1) | CA2583332C (pl) |
| DE (1) | DE502005008880D1 (pl) |
| DK (1) | DK1802277T3 (pl) |
| EA (1) | EA011391B1 (pl) |
| ES (1) | ES2339577T3 (pl) |
| NZ (1) | NZ554183A (pl) |
| PL (1) | PL1802277T3 (pl) |
| PT (1) | PT1802277E (pl) |
| SI (1) | SI1802277T1 (pl) |
| WO (1) | WO2006042701A1 (pl) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040018237A1 (en) * | 2002-05-31 | 2004-01-29 | Perricone Nicholas V. | Topical drug delivery using phosphatidylcholine |
| CN101269212B (zh) * | 2008-04-30 | 2013-09-18 | 上海麟翔生物技术有限公司 | 一种可吞咽的漱口液 |
| DE102009031274A1 (de) * | 2009-06-30 | 2011-01-13 | Justus-Liebig-Universität Giessen | Liposomen zur pulmonalen Applikation |
| LT2523669T (lt) * | 2010-01-11 | 2017-04-25 | Inotek Pharmaceuticals Corporation | Akispūdžio mažinimo būdas, derinys ir rinkinys |
| JP2013523809A (ja) * | 2010-04-05 | 2013-06-17 | エスケー ケミカルズ カンパニー リミテッド | Ｐｄｅ５抑制剤を含む皮膚しわ改善用組成物 |
| CO6280050A1 (es) * | 2010-06-08 | 2011-05-20 | Sante S A Lab | Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa |
| RU2482847C2 (ru) * | 2010-11-17 | 2013-05-27 | Леонид Леонидович Клопотенко | Фармацевтическая композиция, содержащая силденафил или алпростадил, миноксидил или эуфиллин, тестостерон или йохимбин и липосомы для местного применения |
| CA2834968C (en) * | 2011-01-05 | 2018-01-09 | Livon Laboratories | Methods of making liposomes, liposome compositions made by the methods, and methods of using the same |
| CN103547258B (zh) | 2011-03-17 | 2017-10-20 | 特兰斯德梅尔生物工艺股份有限公司 | 局部一氧化氮系统及其使用方法 |
| JP5872060B2 (ja) * | 2011-12-26 | 2016-03-01 | トライテック バイオファーマシューティカルズ カンパニー リミテッドＴｒｉｔｅｃｈ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏ．， Ｌｔｄ． | Ｐｄｅ−５インヒビターの経皮送達を増強するための方法および改良された医薬組成物 |
| US9445993B2 (en) * | 2012-04-16 | 2016-09-20 | Rutgers, The State University Of New Jersey | Nanotechnology approach for inhalation therapies |
| US8871262B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Compositions and methods for treatment of osteoporosis and other indications |
| US8871259B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Techniques and systems for treatment of neuropathic pain and other indications |
| US8871254B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
| US8871255B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment of skin and soft tissue infection with nitric oxide |
| US8871260B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and compositions for muscular and neuromuscular diseases |
| US8871261B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Cancer treatments and compositions for use thereof |
| US8871257B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery |
| US8871258B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment and prevention of learning and memory disorders |
| US8871256B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and systems for treatment of inflammatory diseases with nitric oxide |
| US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
| US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US20140271937A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
| US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US20140271938A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US9750787B2 (en) | 2013-03-13 | 2017-09-05 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US20140271731A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
| US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| EP3119420B1 (en) * | 2014-03-20 | 2021-09-22 | Technion Research & Development Foundation Ltd. | Delivery system comprising a proteolytic enzyme or effector thereof for use in a method for oral treatment and uses thereof |
| ES2973098T3 (es) * | 2015-03-16 | 2024-06-18 | Mireca Medicines Gmbh | Administración liposomal dirigida de análogos de CGMP |
| US20190110988A1 (en) * | 2017-10-17 | 2019-04-18 | Lemulsa Technologies Inc. | Delivery System That Utilizes Liposomal or Emulsion Vehicles |
| IL292775A (en) * | 2019-11-08 | 2022-07-01 | Vella Bioscience Inc | preparations containing cannabidiol (cbd) that act peripherally and their use to improve female sexual function or to treat female sexual disorders |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2026340B (en) * | 1978-07-03 | 1982-12-22 | Ash P | Stabilising microvesicles |
| MX9203808A (es) * | 1987-03-05 | 1992-07-01 | Liposome Co Inc | Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos. |
| US4937078A (en) | 1988-08-26 | 1990-06-26 | Mezei Associates Limited | Liposomal local anesthetic and analgesic products |
| IL91664A (en) | 1988-09-28 | 1993-05-13 | Yissum Res Dev Co | Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release |
| GB9301192D0 (en) | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
| FR2716110B1 (fr) * | 1994-02-16 | 1996-04-05 | Roussel Uclaf | Compositions cosmétiques ou pharmaceutiques comprenant des liposomes. |
| NZ296098A (en) | 1994-11-04 | 2001-05-25 | Polymun Scient Immunbio Forsch | Super oxide dismutase in liposome and it's use in therapy |
| US5731339A (en) * | 1995-04-28 | 1998-03-24 | Zonagen, Inc. | Methods and formulations for modulating the human sexual response |
| US20040014761A1 (en) | 1997-10-28 | 2004-01-22 | Place Virgil A. | Treatment of female sexual dysfunction with phosphodiesterase inhibitors |
| JP2003525845A (ja) * | 1997-10-28 | 2003-09-02 | ヴィヴァス・インコーポレイテッド | 勃起機能不全の処置のためのホスホジエステラーゼインヒビターの局所投与 |
| RU2130771C1 (ru) * | 1998-06-01 | 1999-05-27 | Автушенко Сергей Сергеевич | Способ получения липосомальных препаратов |
| GB9813100D0 (en) * | 1998-06-18 | 1998-08-19 | Secr Defence | Method of forming liposomes |
| TWI223598B (en) | 1998-06-22 | 2004-11-11 | Pfizer Ireland Pharmaceuticals | An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate |
| IT1312310B1 (it) * | 1999-05-07 | 2002-04-15 | Recordati Ind Chimica E Farma | Uso di antagonisti selettivi del recettore adrenergico a 1b per ilmiglioramento della disfunzione sessuale |
| AU2001261244B2 (en) * | 2000-05-09 | 2006-08-03 | Nitromed, Inc. | Infrared thermography and methods of use |
| US7223406B2 (en) * | 2000-07-21 | 2007-05-29 | The Regents Of The University Of California | Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder |
| EP1203614A1 (de) | 2000-11-03 | 2002-05-08 | Polymun Scientific Immunbiologische Forschung GmbH | Verfahren und Vorrichtung zur Herstellung von Lipidvesikeln |
| CA2460209A1 (en) | 2001-09-06 | 2003-04-24 | Yechezkel Barenholz | A method for preparing liposome formulations with a predefined release profile |
| US6833139B1 (en) * | 2002-01-09 | 2004-12-21 | Ferndale Laboratories, Inc. | Composition and method for the treatment of anorectal disorders |
| EP1519714B1 (en) * | 2002-06-28 | 2010-10-20 | Protiva Biotherapeutics Inc. | Method and apparatus for producing liposomes |
| WO2004047800A2 (en) * | 2002-11-26 | 2004-06-10 | Gilead Sciences, Inc. | Method of drug loading in liposomes by gradient |
-
2005
- 2005-10-14 DK DK05802312.8T patent/DK1802277T3/da active
- 2005-10-14 AU AU2005296719A patent/AU2005296719B2/en not_active Ceased
- 2005-10-14 KR KR1020077008391A patent/KR101289917B1/ko not_active Expired - Fee Related
- 2005-10-14 NZ NZ554183A patent/NZ554183A/en not_active IP Right Cessation
- 2005-10-14 PL PL05802312T patent/PL1802277T3/pl unknown
- 2005-10-14 DE DE502005008880T patent/DE502005008880D1/de not_active Expired - Lifetime
- 2005-10-14 EA EA200700892A patent/EA011391B1/ru not_active IP Right Cessation
- 2005-10-14 JP JP2007536100A patent/JP5688199B2/ja not_active Expired - Fee Related
- 2005-10-14 WO PCT/EP2005/011054 patent/WO2006042701A1/de not_active Ceased
- 2005-10-14 SI SI200530965T patent/SI1802277T1/sl unknown
- 2005-10-14 US US11/577,488 patent/US8524274B2/en not_active Expired - Fee Related
- 2005-10-14 CN CNA2005800356693A patent/CN101043874A/zh active Pending
- 2005-10-14 PT PT05802312T patent/PT1802277E/pt unknown
- 2005-10-14 AT AT05802312T patent/ATE454884T1/de active
- 2005-10-14 CA CA2583332A patent/CA2583332C/en not_active Expired - Fee Related
- 2005-10-14 EP EP05802312A patent/EP1802277B1/de not_active Expired - Lifetime
- 2005-10-14 ES ES05802312T patent/ES2339577T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE502005008880D1 (de) | 2010-03-04 |
| AU2005296719B2 (en) | 2011-02-03 |
| ES2339577T3 (es) | 2010-05-21 |
| JP2008516911A (ja) | 2008-05-22 |
| KR20070069164A (ko) | 2007-07-02 |
| EA200700892A1 (ru) | 2007-08-31 |
| PT1802277E (pt) | 2010-04-01 |
| US8524274B2 (en) | 2013-09-03 |
| SI1802277T1 (sl) | 2010-05-31 |
| KR101289917B1 (ko) | 2013-07-25 |
| AU2005296719A1 (en) | 2006-04-27 |
| JP5688199B2 (ja) | 2015-03-25 |
| US20090324698A1 (en) | 2009-12-31 |
| EP1802277A1 (de) | 2007-07-04 |
| CN101043874A (zh) | 2007-09-26 |
| EP1802277B1 (de) | 2010-01-13 |
| DK1802277T3 (da) | 2010-05-17 |
| EA011391B1 (ru) | 2009-02-27 |
| ATE454884T1 (de) | 2010-01-15 |
| WO2006042701A1 (de) | 2006-04-27 |
| CA2583332C (en) | 2013-10-01 |
| CA2583332A1 (en) | 2006-04-27 |
| NZ554183A (en) | 2009-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1802277T1 (sl) | Liposomalni sestavek ki vsebuje učinkovino za relaksiranje gladke muskulature priprava tega sestavka in njegova terapevtska uporaba | |
| PY0228832A (es) | Formulaciones farmaceuticas de 5,7,14-triazatetra-ciclo [10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaeno | |
| UA90858C2 (ru) | Композиция с контролируемым высвобождением варденафила | |
| WO2003000343A3 (en) | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation | |
| AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
| MY148773A (en) | Galenic formulations of organic compounds | |
| MXPA04004173A (es) | Formas orales de liberacion controlada utiles para la reduccion o prevencion de la ansiedad hacia la nicotina. | |
| BR0210261A (pt) | Formulações farmacêuticas para a administração eficiente de apomorfina, 6ar-(-)-n-propil-norapomorfina e seus derivados e pró-drogas destes | |
| IL151519A0 (en) | Anti-infective active substance combinations and the use thereof for the topical treatment of fungus disease of toe and finger nails | |
| UY27740A1 (es) | Nuevos compuestos | |
| AU2020278236A8 (en) | Methods of treating Sjögren's Syndrome using a Bruton's tyrosine kinase inhibitor | |
| PT1173181E (pt) | Composicao compreendendo os inibidores da fosfodiesterase para tratar disfuncoes sexuais | |
| ES2189871T3 (es) | Ciclohexil-dihidro-benzofuranos. | |
| SE0102055D0 (sv) | New Compounds | |
| MXPA03010054A (es) | Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos. | |
| PT1414467E (pt) | Tratamento topico da mastalgia | |
| SE0102440D0 (sv) | New compound | |
| BR0311903A (pt) | Tratamento para depressão e ansiedade pela combinação de um inibidor de pde iv e um agente antidepressivo ou ansiolìtico | |
| TW200606164A (en) | New compounds | |
| WO2023114369A3 (en) | Topical formulations of pi3k-delta inhibitors | |
| TW200800984A (en) | New compounds | |
| WO2006115770A3 (en) | Orally disintegrating pharmaceutical tablet formulations of olanzapine | |
| BRPI0416202A (pt) | formulações inibidoras de fosfodiesterase v | |
| WO2004033484A3 (en) | Use of stable glutamine derivatives to improve drug absorption | |
| HRPK20040328B3 (en) | Pharmaceutical composition comprising gamma-butyrobetaine |